SEC Form 4 · accession 0001628280-26-048170
Alignment Healthcare, Inc. · ALHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Kao
Officer — Chief Executive Officer · Director
Period of report
Jul 10, 2026
Accepted (ET)
Jul 14, 2026 · 4:47 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001832466
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jul 10, 2026 | S | 279,644 | $19.8122 | D | 1,107,122 | I | See Footnote |
| Common StockF4,F3 | Jul 10, 2026 | S | 18,356 | $20.6471 | D | 1,088,766 | I | See Footnote |
| Common Stock | holding | — | — | — | 1,608,743 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Date of Rule 10b5-1 plan adoption: 11/21/2025
- F2The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.55 to $20.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- F3Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
- F4The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.55 to $20.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.